A new pilot program from the federal government has hospital and pharmacy leaders bracing for what they describe as a fundamental dismantling of the ...

The dramatic growth of a key federal drug discount program has fueled debate about whether it is helping low-income patients as intended or primarily benefiting health care providers.

If HHS' 340B rebate model pilot proceeds as planned, more than 2,700 U.S. hospitals will collectively be saddled with approximately $400 million ...

Hospitals and major drugmakers are battling over the financial impact of a government pilot program that could shake up how ...

AHA comments on the Health Resources and Services Administration’s (HRSA) information collection request (ICR) regarding the expected costs of its 340B Rebate Model Pilot Program.

The anticipated burdens on hospitals to comply with the Health Resources and Services Administration’s 340B Rebate Pilot Program far exceed the agency’s estimates, and HRSA should delay the program’s ...

A judge upholds Maine's contract pharmacy law, rejecting drugmakers' claims that it conflicts with federal rules governing ...

A new chapter in the 340B Drug Pricing Program is unfolding as the Health Resources & Services Administration (“HRSA”) ...

One of the world’s biggest drug makers is suing the country’s smallest state. The argument is over a federal drug discount program ...

Stitt and other Republican governors argue that drug discounts can be used to support abortion services indirectly.

The article 🌱 Patch AM: 340B program vital for healthcare in Chicago Heights appeared first on Chicago Heights Patch. Good ...

On Wednesday, health care providers and drug manufacturers hotly debated legislation looking to ensure hospitals can purchase ...